Turkish Validity and Reliability of Physiotherapist Self-Efficacy Questionnaire

Sponsor
Istanbul Bilgi University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05335291
Collaborator
(none)
156
1
8.9
17.6

Study Details

Study Description

Brief Summary

The aim of this study is to provide Turkish validation and determine the validity of the "Physiotherapist Self-Efficacy Questionnaire".

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire study

Detailed Description

Self-efficacy is defined as one's belief in one's existing capacity to perform the necessary behavior in a specific situation. "Physiotherapist Self-Efficacy Questionnaire" has been developed to be used in the assessment of self-efficacy for the field of physiotherapy and rehabilitation. In this scale, there are 13 items about how competent the individual feels in clinical assessment, problem solving, planning, and communication related to caseloads.

It has been shown that the scale is a valid and reliable method in cardiorespiratory, musculoskeletal and neurological clinical fields, which are special areas of physiotherapy and rehabilitation.

Study Design

Study Type:
Observational
Anticipated Enrollment :
156 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Turkish Validity and Reliability Study of Physiotherapist Self-Efficacy Questionnaire
Actual Study Start Date :
Apr 6, 2022
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Jan 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Group I

Other: Questionnaire study
The Turkish validity and reliability of the questionnaire will be examined.

Outcome Measures

Primary Outcome Measures

  1. Turkish version of Physiotherapist Self-Efficacy Questionnaire-cardiorespiratory area [Baseline and after one week]

    The questionnaire consists of 13 items. The participants will asked to indicate their confidence to perform the described task (1 = very little confidence; 5 = a lot of confidence). Higher scores are related more confidence self-efficacy.

  2. Turkish version of Physiotherapist Self-Efficacy Questionnaire-musculoskeletal area [Baseline and after one week]

    The questionnaire consists of 13 items. The participants will asked to indicate their confidence to perform the described task (1 = very little confidence; 5 = a lot of confidence). Higher scores are related more confidence self-efficacy.

  3. Turkish version of Physiotherapist Self-Efficacy Questionnaire-neurological area [Baseline and after one week]

    The questionnaire consists of 13 items. The participants will asked to indicate their confidence to perform the described task (1 = very little confidence; 5 = a lot of confidence). Higher scores are related more confidence self-efficacy.

Secondary Outcome Measures

  1. General Self-Efficacy Scale [Baseline]

    This scale consists of 10 items. The answers are in a four-likert form (completely true, somewhat true, moderately accurate, completely wrong).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Able to speak, read, understand and write in Turkish

  • Physiotherapy and rehabilitation students who have participated in at least one clinical practice

  • Physiotherapists working in the clinic

Exclusion Criteria:
  • Having cognitive problems

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul Bilgi University Istanbul Turkey

Sponsors and Collaborators

  • Istanbul Bilgi University

Investigators

  • Principal Investigator: Aycan Cakmak Reyhan, PT, phD, Istanbul Bilgi University
  • Principal Investigator: Tugba Kuru Colak, PT, phD, Marmara University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Cigdem Emirza, Research Assistant, Istanbul Bilgi University
ClinicalTrials.gov Identifier:
NCT05335291
Other Study ID Numbers:
  • 20022-40030-32
First Posted:
Apr 19, 2022
Last Update Posted:
Aug 18, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cigdem Emirza, Research Assistant, Istanbul Bilgi University

Study Results

No Results Posted as of Aug 18, 2022